Non-thermal dielectric barrier discharge plasma induces angiogenesis through reactive oxygen species

Vascularization plays a key role in processes such as wound healing and tissue engineering. Non-thermal plasma, which primarily produces reactive oxygen species (ROS), has recently emerged as an efficient tool in medical applications including blood coagulation, sterilization and malignant cell apoptosis. Liquids and porcine aortic endothelial cells were treated with a non-thermal dielectric barrier discharge plasma in vitro. Plasma treatment of phosphate-buffered saline (PBS) and serum-free medium increased ROS concentration in a dose-dependent manner, with a higher concentration observed in serum-free medium compared with PBS. Species concentration inside cells peaked 1 h after treatment, followed by a decrease 3 h post treatment. Endothelial cells treated with a plasma dose of 4.2 J cm–2 had 1.7 times more cells than untreated samples 5 days after plasma treatment. The 4.2 J cm–2 plasma dose increased two-dimensional migration distance by 40 per cent compared with untreated control, while the number of cells that migrated through a three-dimensional collagen gel increased by 15 per cent. Tube formation was also enhanced by plasma treatment, with tube lengths in plasma-treated samples measuring 2.6 times longer than control samples. A fibroblast growth factor-2 (FGF-2) neutralizing antibody and ROS scavengers abrogated these angiogenic effects. These data indicate that plasma enhanced proliferation, migration and tube formation is due to FGF-2 release induced by plasma-produced ROS. Non-thermal plasma may be used as a potential tool for applying ROS in precise doses to enhance vascularization.

[1]  Matthias Schäfer,et al.  Oxidative stress in normal and impaired wound repair. , 2008, Pharmacological research.

[2]  M. Reed,et al.  Neovascularization in aged mice: delayed angiogenesis is coincident with decreased levels of transforming growth factor beta1 and type I collagen. , 1998, The American journal of pathology.

[3]  E. Bourdon,et al.  The antioxidant properties of serum albumin , 2008, FEBS letters.

[4]  Pierre Alusta,et al.  Contribution of a portable air plasma torch to rapid blood coagulation as a method of preventing bleeding , 2009 .

[5]  Savita Khanna,et al.  Dermal wound healing is subject to redox control. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  B. Violand,et al.  PROTEIN AND PEPTIDE CHEMICAL AND PHYSICAL STABILITY , 2000 .

[7]  D. Rifkin,et al.  Biological roles of fibroblast growth factor-2. , 1997, Endocrine reviews.

[8]  P. Delafontaine,et al.  Reactive oxygen species stimulate insulin-like growth factor I synthesis in vascular smooth muscle cells. , 1997, Cardiovascular research.

[9]  K. Bland,et al.  Experimental and Clinical Observations of the Effects of Cytotoxic Chemotherapeutic Drugs on Wound Healing , 1984, Annals of surgery.

[10]  J. Last,et al.  EGF-Receptor phosphorylation and signaling are targeted by H2O2 redox stress. , 1998, American journal of respiratory cell and molecular biology.

[11]  N. Ferrara VEGF and its receptors , 2004 .

[12]  M. Simons,et al.  Growth factor-induced therapeutic angiogenesis in the heart: protein therapy. , 2005, Cardiovascular research.

[13]  Gregor E. Morfill,et al.  Plasma medicine: an introductory review , 2009 .

[14]  L. Claesson‐Welsh,et al.  FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. , 2001, Trends in pharmacological sciences.

[15]  P. Carmeliet,et al.  Conditional switching of VEGF provides new insights into adult neovascularization and pro‐angiogenic therapy , 2002, The EMBO journal.

[16]  J. Raiser,et al.  Argon plasma coagulation for open surgical and endoscopic applications: state of the art , 2006 .

[17]  T. K. Hunt,et al.  The future of recombinant growth factors in wound healing. , 1998, American journal of surgery.

[18]  Anthony Atala,et al.  Engineering Complex Tissues , 2012, Science Translational Medicine.

[19]  S. W. Lin,et al.  Protein damage and degradation by oxygen radicals. II. Modification of amino acids. , 1987, The Journal of biological chemistry.

[20]  D. Butterfield,et al.  Protein carbonylation. , 2010, Antioxidants & redox signaling.

[21]  Michael Simons,et al.  Antiangiogenic plasma activity in patients with systemic sclerosis. , 2007, Arthritis and rheumatism.

[22]  E. Kardami,et al.  Transcriptional regulation of FGF-2 gene expression in cardiac myocytes. , 2004, Cardiovascular research.

[23]  H. Ischiropoulos,et al.  Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. , 1992, Chemical research in toxicology.

[24]  H. Randeva,et al.  Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. , 2008, Cardiovascular research.

[25]  J. Schjoerring,et al.  Specific Aquaporins Facilitate the Diffusion of Hydrogen Peroxide across Membranes* , 2007, Journal of Biological Chemistry.

[26]  T. Collins,et al.  Modulation of growth factor gene expression in vascular cells by oxidative stress. , 2004, Endothelium : journal of endothelial cell research.

[27]  R. Salganik The Benefits and Hazards of Antioxidants: Controlling Apoptosis and Other Protective Mechanisms in Cancer Patients and the Human Population , 2001, Journal of the American College of Nutrition.

[28]  Daniel B. Rifkin,et al.  Fibroblast Growth Factor-2 (FGF-2) Induces Vascular Endothelial Growth Factor (VEGF) Expression in the Endothelial Cells of Forming Capillaries: An Autocrine Mechanism Contributing to Angiogenesis , 1998, The Journal of cell biology.

[29]  L. Zhang,et al.  Protein Carbonylation as a Novel Mechanism in Redox Signaling , 2008, Circulation research.

[30]  J. Michaeli,et al.  Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. , 1994, Cancer research.

[31]  A. Visser,et al.  Fluorescence detection of enzymatically formed hydrogen peroxide in aqueous solution and in reversed micelles. , 1990, Analytical biochemistry.

[32]  N. Bibinov,et al.  Basics and Biomedical Applications of Dielectric Barrier Discharge (DBD) , 2011 .

[33]  P. Libby,et al.  Mechanical strain tightly controls fibroblast growth factor-2 release from cultured human vascular smooth muscle cells. , 1997, Circulation research.

[34]  Kyongbum Lee,et al.  Vascularization strategies for tissue engineering. , 2009, Tissue engineering. Part B, Reviews.

[35]  S. Jeng,et al.  Far‐Infrared Radiation Promotes Angiogenesis in Human Microvascular Endothelial Cells via Extracellular Signal‐Regulated Kinase Activation , 2011, Photochemistry and photobiology.

[36]  S. Naito,et al.  Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. , 1998, Life sciences.

[37]  Gregory Fridman,et al.  Comparison of Direct and Indirect Effects of Non‐Thermal Atmospheric‐Pressure Plasma on Bacteria , 2007 .

[38]  J. Schwartz,et al.  Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. , 1994, Cancer research.

[39]  A. Passaniti,et al.  A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[40]  J. Folkman,et al.  Transcriptional regulation of basic fibroblast growth factor gene expression in capillary endothelial cells , 1991, Journal of cellular biochemistry.

[41]  S. Wedgwood,et al.  Regulation of fibroblast growth factor-2 expression in pulmonary arterial smooth muscle cells involves increased reactive oxygen species generation. , 2008, American journal of physiology. Cell physiology.

[42]  D. Sane,et al.  Abnormal angiogenesis in diabetes mellitus , 2003, Medicinal research reviews.

[43]  A. Gotlieb,et al.  In vitro reendothelialization of a single-cell wound. Role of microfilament bundles in rapid lamellipodia-mediated wound closure. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[44]  Masayuki Yamato,et al.  Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  J. Vivekananda,et al.  Acute inflammatory injury in the lung precipitated by oxidant stress induces fibroblasts to synthesize and release transforming growth factor-alpha. , 1994, The Journal of biological chemistry.

[46]  P. Mcneil,et al.  Growth factors are released by mechanically wounded endothelial cells , 1989, Journal of Cell Biology.

[47]  H. Kanetake,et al.  Stromal cell-derived factor-1alpha induces tube-like structure formation of endothelial cells through phosphoinositide 3-kinase. , 2003, The Journal of biological chemistry.

[48]  T. K. Hunt,et al.  Oxidant-induced Vascular Endothelial Growth Factor Expression in Human Keratinocytes and Cutaneous Wound Healing* , 2002, The Journal of Biological Chemistry.

[49]  P. Mcneil,et al.  Mini-review Loss, Restoration, and Maintenance of Plasma Membrane Integrity Occurrence of Mechanically Initiated Plasma Membrane Disruptions Surviving/resealing Plasma Membrane Disruptions , 2022 .

[50]  Ari,et al.  Non-thermal Plasma Induces Apoptosis in Melanoma Cells via Production of Intracellular Reactive Oxygen Species , 2010 .

[51]  A. Fridman,et al.  Heating Effect of Dielectric Barrier Discharges for Direct Medical Treatment , 2009, IEEE Transactions on Plasma Science.

[52]  R Langer,et al.  Controlled and modulated release of basic fibroblast growth factor. , 1991, Biomaterials.

[53]  L. Bourguignon,et al.  Electric stimulation of protein and DNA synthesis in human fibroblasts , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  N. Bibinov,et al.  Characterization of DBD plasma source for biomedical applications , 2009 .

[55]  Wei Sun,et al.  Effect of Dielectric Barrier Discharge Plasma on the Attachment and Proliferation of Osteoblasts Cultured over Poly(ε‐caprolactone) Scaffolds , 2008 .

[56]  J. C. Barrett,et al.  PART 1 : THE ROLE OF ROS IN HEALTH AND DISEASE OXIDANTS AND ANTIOXIDATIVE DEFENSE , 2002 .

[57]  Rakesh K. Jain,et al.  Quantitative angiogenesis assays: Progress and problems , 1997, Nature Medicine.

[58]  E. Stadtman,et al.  Fenton chemistry. Amino acid oxidation. , 1991, The Journal of biological chemistry.

[59]  J. Balligand,et al.  Regulation of bFGF expression and ANG II secretion in cardiac myocytes and microvascular endothelial cells. , 1997, The American journal of physiology.

[60]  R O Bonow,et al.  Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary. , 2000, Circulation.

[61]  M. Tibbs,et al.  Wound healing following radiation therapy: a review. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[62]  P. Lazarovici,et al.  Nerve Growth Factor-Induced Migration of Endothelial Cells , 2005, Journal of Pharmacology and Experimental Therapeutics.

[63]  T. Galeotti,et al.  Reactive Oxygen Species as Downstream Mediators of Angiogenic Signaling by Vascular Endothelial Growth Factor Receptor-2/KDR* , 2002, The Journal of Biological Chemistry.

[64]  F. Levi-Schaffer,et al.  Role of reactive oxygen species (ROS) in apoptosis induction , 2000, Apoptosis.

[65]  I. Soloshenko Sterilization of medical products in low-pressure glow discharges Plasma , 2000 .

[66]  C. Schmidt,et al.  Vascular graft endothelialization: comparative analysis of canine and human endothelial cell migration on natural biomaterials. , 2001, Journal of biomedical materials research.

[67]  Y. Kataoka,et al.  Relationship between Phosphorylated Histone H2AX Formation and Cell Survival in Human Microvascular Endothelial Cells (HMEC) as a Function of Ionizing Radiation Exposure in the Presence or Absence of Thiol-Containing Drugs , 2007, Radiation research.

[68]  A. Popel,et al.  A peptide derived from type 1 thrombospondin repeat-containing protein WISP-1 inhibits corneal and choroidal neovascularization. , 2009, Investigative ophthalmology & visual science.

[69]  E. Edelman,et al.  Glucose Modulates Basement Membrane Fibroblast Growth Factor-2 via Alterations in Endothelial Cell Permeability* , 2007, Journal of Biological Chemistry.

[70]  P. Dell’Era,et al.  Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. , 2005, Cytokine & growth factor reviews.

[71]  J. Zimmermann,et al.  Focus on Plasma Medicine , 2009 .

[72]  G. Neufeld,et al.  Vascular endothelial growth factor (VEGF) and its receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[73]  K. Scharffetter-Kochanek,et al.  Oxidative stress in chronic venous leg ulcers , 2005, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[74]  Paolo A Netti,et al.  Induction of directional sprouting angiogenesis by matrix gradients. , 2007, Journal of biomedical materials research. Part A.

[75]  S. Jain The accumulation of malonyldialdehyde, a product of fatty acid peroxidation, can disturb aminophospholipid organization in the membrane bilayer of human erythrocytes. , 1984, The Journal of biological chemistry.

[76]  P. Moore,et al.  The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. , 2007, Cardiovascular research.

[77]  R. Alexander,et al.  Reactive oxygen species as mediators of angiogenesis signaling. Role of NAD(P)H oxidase , 2004, Molecular and Cellular Biochemistry.

[78]  P. Mcneil,et al.  Basic fibroblast growth factor is efficiently released from a cytolsolic storage site through plasma membrane disruptions of endothelial cells , 1991, Journal of cellular physiology.

[79]  J. Schjoerring,et al.  Membrane transport of hydrogen peroxide. , 2006, Biochimica et biophysica acta.

[80]  R. Walraven,et al.  Plasma treatment of dental cavities: a feasibility study , 2004, IEEE Transactions on Plasma Science.

[81]  A. Clyne,et al.  Endothelial Cell Proliferation is Enhanced by Low Dose Non-Thermal Plasma Through Fibroblast Growth Factor-2 Release , 2010, Annals of Biomedical Engineering.

[82]  A. Shekhter,et al.  Beneficial effect of gaseous nitric oxide on the healing of skin wounds. , 2005, Nitric oxide : biology and chemistry.

[83]  J. Herbert,et al.  The mitogenic effect of H2O2 for vascular smooth muscle cells is mediated by an increase of the affinity of basic fibroblast growth factor for its receptor , 1996, FEBS letters.

[84]  Gregory Fridman,et al.  Blood Coagulation and Living Tissue Sterilization by Floating-Electrode Dielectric Barrier Discharge in Air , 2006 .

[85]  H. Kanetake,et al.  Stromal Cell-derived Factor-1α Induces Tube-like Structure Formation of Endothelial Cells through Phosphoinositide 3-Kinase* , 2003, The Journal of Biological Chemistry.

[86]  T. Finkel Signal transduction by reactive oxygen species in non‐phagocytic cells , 1999, Journal of leukocyte biology.

[87]  Alexander Gutsol,et al.  Atmospheric pressure plasma of dielectric barrier discharges , 2005 .

[88]  P. Ku,et al.  Regulation of basic fibroblast growth factor (bFGF) gene and protein expression following its release from sublethally injured endothelial cells , 1995, Journal of cellular biochemistry.

[89]  T. Finkel Redox‐dependent signal transduction , 2000, FEBS letters.

[90]  C. Joo,et al.  Reactive oxygen species-induced apoptosis and necrosis in bovine corneal endothelial cells. , 1999, Investigative ophthalmology & visual science.

[91]  N. Bazan,et al.  Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells. , 2004, Investigative ophthalmology & visual science.

[92]  G. Friedman,et al.  Comparison of Direct and Indirect Effects of Non-Thermal Atmospheric Pressure Plasma on Bacteria and Mechanisms of Such Interaction , 2007, 2007 IEEE 34th International Conference on Plasma Science (ICOPS).

[93]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[94]  E. Edelman,et al.  Elevated fibroblast growth factor‐2 increases tumor necrosis factor‐α induced endothelial cell death in high glucose , 2008, Journal of cellular physiology.

[95]  J. Zweier,et al.  Hydrogen peroxide and superoxide modulate leukocyte adhesion molecule expression and leukocyte endothelial adhesion. , 1996, Biochimica et biophysica acta.

[96]  Jeroen Rouwkema,et al.  Vascularization in tissue engineering. , 2008, Trends in biotechnology.

[97]  T. Slater Free-radical mechanisms in tissue injury. , 1984, The Biochemical journal.

[98]  B. Eliasson,et al.  Modelling of dielectric barrier discharge chemistry , 1994 .

[99]  F. Sellke,et al.  THE FUTURE OF THERAPEUTIC MYOCARDIAL ANGIOGENESIS , 2006, Shock.

[100]  Bruce Simon,et al.  Electromagnetic fields increase in vitro and in vivo angiogenesis through endothelial release of FGF‐2 , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[101]  Amber N. Stratman,et al.  In vitro three dimensional collagen matrix models of endothelial lumen formation during vasculogenesis and angiogenesis. , 2008, Methods in enzymology.

[102]  Gregory Fridman,et al.  Applied Plasma Medicine , 2008 .

[103]  J. Gebicki,et al.  Formation of peroxides in amino acids and proteins exposed to oxygen free radicals. , 1993, The Biochemical journal.

[104]  B. Ames,et al.  Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay. , 1983, Analytical biochemistry.

[105]  Gregory Fridman,et al.  Mechanism of Blood Coagulation by Nonthermal Atmospheric Pressure Dielectric Barrier Discharge Plasma , 2007, IEEE Transactions on Plasma Science.

[106]  A. Haimovitz-Friedman,et al.  Effects of irradiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells. , 1989, Cancer research.

[107]  S. Finklestein,et al.  Increased basic fibroblast growth factor (bFGF) immunoreactivity at the site of focal brain wounds , 1988, Brain Research.

[108]  Q. Yu,et al.  Transient disruptions of aortic endothelial cell plasma membranes. , 1992, The American journal of pathology.

[109]  K. Chowdhury,et al.  Free radicals induce gene expression of NGF and bFGF in rat astrocyte culture , 1992, Neuroreport.

[110]  F. Yuan,et al.  Dose response of angiogenesis to basic fibroblast growth factor in rat corneal pocket assay: I. Experimental characterizations. , 2008, Microvascular research.

[111]  M. Nugent,et al.  Fibroblast growth factor-2. , 2000, The international journal of biochemistry & cell biology.

[112]  G. Camussi,et al.  Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. , 1995, Journal of immunology.